Filing Flows › Kestra Medical Technologies (KMTS) › R&D spending
Kestra Medical Technologies (KMTS) R&D spending by quarter
Kestra Medical Technologies' R&D spending was $6.8M in Q1 FY27 (first quarter fiscal 2027), +21% from Q4 FY26. Over the last 7 quarters it ranged from $3.4M (Q3 FY25) to $6.8M (Q1 FY27).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $6.8M | +21% | +70% |
| Q4 FY26 | $5.6M | +13% | +5% |
| Q3 FY26 | $5.0M | +2% | +48% |
| Q2 FY26 | $4.9M | +22% | — |
| Q1 FY26 | $4.0M | -26% | — |
| Q4 FY25 | $5.4M | +61% | — |
| Q3 FY25 | $3.4M | — | — |
Q1 FY27 at a glance
Kestra Medical Technologies, Q1 FY27: revenue $31.0M (+60% year over year), operating margin -121.6%, net loss $44.1M, operating cash flow −$32.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Kestra Medical Technologies' R&D spending?
Kestra Medical Technologies' R&D spending was $6.8M in Q1 FY27 (first quarter fiscal 2027), +21% from Q4 FY26.
How has Kestra Medical Technologies' R&D spending changed?
Over the last 7 quarters it ranged from $3.4M (Q3 FY25) to $6.8M (Q1 FY27).
Q1 FY27 results → · How Kestra Medical Technologies makes money →